122 related articles for article (PubMed ID: 23639870)
1. Levetiracetam but not valproate inhibits function of CD8+ T lymphocytes.
Li G; Nowak M; Bauer S; Schlegel K; Stei S; Allenhöfer L; Waschbisch A; Tackenberg B; Höllerhage M; Höglinger GU; Wegner S; Wang X; Oertel WH; Rosenow F; Hamer HM
Seizure; 2013 Jul; 22(6):462-6. PubMed ID: 23639870
[TBL] [Abstract][Full Text] [Related]
2. Effects of levetiracetam and valproate on reproductive endocrine function studied in human ovarian follicular cells.
Taubøll E; Gregoraszczuk EL; Wojtowicz AK; Milewicz T
Epilepsia; 2009 Aug; 50(8):1868-74. PubMed ID: 19490055
[TBL] [Abstract][Full Text] [Related]
3. Comparison of reproductive effects of levetiracetam and valproate studied in prepubertal porcine ovarian follicular cells.
Taubøll E; Gregoraszczuk EL; Tworzydø A; Wójtowicz AK; Ropstad E
Epilepsia; 2006 Sep; 47(9):1580-3. PubMed ID: 16981877
[TBL] [Abstract][Full Text] [Related]
4. Effects of valproic acid (VPA) and levetiracetam (LEV) on proliferation, apoptosis and hormone secretion of the human choriocarcinoma BeWo cell line.
Kwiecińska P; Wiśniewska J; Gregoraszczuk EŁ
Pharmacol Rep; 2011; 63(5):1195-202. PubMed ID: 22180362
[TBL] [Abstract][Full Text] [Related]
5. The effects of levetiracetam, carbamazepine, and sodium valproate on P100 and P300 in epileptic patients.
Tumay Y; Altun Y; Ekmekci K; Ozkul Y
Clin Neuropharmacol; 2013; 36(2):55-8. PubMed ID: 23503548
[TBL] [Abstract][Full Text] [Related]
6. Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats.
van Vliet EA; Edelbroek PM; Gorter JA
Epilepsia; 2010 Mar; 51(3):362-70. PubMed ID: 19674045
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of valproic acid and levetiracetam on apoptosis in the human ovarian cancer cell line OVCAR-3.
Kwiecińska P; Taubøll E; Gregoraszczuk EL
Pharmacol Rep; 2012; 64(3):603-14. PubMed ID: 22814014
[TBL] [Abstract][Full Text] [Related]
8. Levetiracetam, phenytoin, and valproate act differently on rat bone mass, structure, and metabolism.
Nissen-Meyer LS; Svalheim S; Taubøll E; Reppe S; Lekva T; Solberg LB; Melhus G; Reinholt FP; Gjerstad L; Jemtland R
Epilepsia; 2007 Oct; 48(10):1850-60. PubMed ID: 17634065
[TBL] [Abstract][Full Text] [Related]
9. Effects of valproic acid and levetiracetam on viability and cell cycle regulatory genes expression in the OVCAR-3 cell line.
Kwiecińska P; Taubøll E; Gregoraszczuk EL
Pharmacol Rep; 2012; 64(1):157-65. PubMed ID: 22580532
[TBL] [Abstract][Full Text] [Related]
10. Effects of valproate, carbamazepine, and levetiracetam on the antioxidant and oxidant systems in epileptic patients and their clinical importance.
Varoglu AO; Yildirim A; Aygul R; Gundogdu OL; Sahin YN
Clin Neuropharmacol; 2010 May; 33(3):155-7. PubMed ID: 20502135
[TBL] [Abstract][Full Text] [Related]
11. Levetiracetam Prevents Perforin Mediated Neuronal Injury Induced by Acute Cerebral Ischemia Reperfusion.
Zhang Y; Li Y; Zuo L; Bao H; Xu X; Hao J; Wang X; Li G
Mol Neurobiol; 2016 Oct; 53(8):5480-91. PubMed ID: 26454821
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein.
Wood MD; Gillard M
Epilepsia; 2017 Feb; 58(2):255-262. PubMed ID: 28012162
[TBL] [Abstract][Full Text] [Related]
13. Isobolographic characterization of the anticonvulsant interaction profiles of levetiracetam in combination with clonazepam, ethosuximide, phenobarbital and valproate in the mouse pentylenetetrazole-induced seizure model.
Dudra-Jastrzebska M; Andres-Mach MM; Ratnaraj N; Patsalos PN; Czuczwar SJ; Luszczki JJ
Seizure; 2009 Nov; 18(9):607-14. PubMed ID: 19628415
[TBL] [Abstract][Full Text] [Related]
14. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs.
Ji-qun C; Ishihara K; Nagayama T; Serikawa T; Sasa M
Epilepsia; 2005 Sep; 46(9):1362-70. PubMed ID: 16146430
[TBL] [Abstract][Full Text] [Related]
15. The effect of valproate and levetiracetam on steroidogenesis in forskolin-stimulated H295R cells.
von Krogh K; Harjen H; Almås C; Zimmer KE; Dahl E; Olsaker I; Taubøll E; Ropstad E; Verhaegen S
Epilepsia; 2010 Nov; 51(11):2280-8. PubMed ID: 20726872
[TBL] [Abstract][Full Text] [Related]
16. Direct and indirect comparison meta-analysis of levetiracetam versus phenytoin or valproate for convulsive status epilepticus.
Brigo F; Bragazzi N; Nardone R; Trinka E
Epilepsy Behav; 2016 Nov; 64(Pt A):110-115. PubMed ID: 27736657
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy.
van Vliet EA; Aronica E; Redeker S; Boer K; Gorter JA
Epilepsia; 2009 Mar; 50(3):422-33. PubMed ID: 18717715
[TBL] [Abstract][Full Text] [Related]
18. Brivaracetam augments short-term depression and slows vesicle recycling.
Yang X; Bognar J; He T; Mohammed M; Niespodziany I; Wolff C; Esguerra M; Rothman SM; Dubinsky JM
Epilepsia; 2015 Dec; 56(12):1899-909. PubMed ID: 26515103
[TBL] [Abstract][Full Text] [Related]
19. Resting-state fMRI revealed different brain activities responding to valproic acid and levetiracetam in benign epilepsy with central-temporal spikes.
Zhang Q; Yang F; Hu Z; Zhang Z; Xu Q; Dante M; Wu H; Li Z; Li Q; Li K; Lu G
Eur Radiol; 2017 May; 27(5):2137-2145. PubMed ID: 27553940
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of antiepileptic drugs on steroidogenesis in a human in vitro cell model.
Gustavsen MW; von Krogh K; Taubøll E; Zimmer KE; Dahl E; Olsaker I; Ropstad E; Verhaegen S
Acta Neurol Scand Suppl; 2009; (189):14-21. PubMed ID: 19566492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
